506128 PARNAXLAB

Parnax Lab Share Price

 

 

Start SIP in PARNAXLAB

Start SIP

Performance

  • Low
  • ₹130
  • High
  • ₹135
  • 52 Week Low
  • ₹81
  • 52 Week High
  • ₹178
  • Open Price₹134
  • Previous Close₹131
  • Volume6,215

Investment Returns

  • Over 1 Month + 7.38%
  • Over 3 Month + 3.4%
  • Over 6 Month + 27.87%
  • Over 1 Year -23.19%

Smart Investing Starts Here Start SIP with Parnax Lab for Steady Growth!

Invest Now

Parnax Lab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.8
  • PEG Ratio
  • -2.1
  • Market Cap Cr
  • 152
  • P/B Ratio
  • 1.7
  • Average True Range
  • 8.63
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.69
  • RSI
  • 58.47
  • MFI
  • 79.69

Parnax Lab Financials

Parnax Lab Technicals

EMA & SMA

Current Price
₹132.35
+ 1.35 (1.03%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹126.42
  • 50 Day
  • ₹125.83
  • 100 Day
  • ₹124.64
  • 200 Day
  • ₹122.39

Resistance and Support

132.13 Pivot Speed
  • R3 139.17
  • R2 137.03
  • R1 134.27
  • S1 129.37
  • S2 127.23
  • S3 124.47

Parnax Lab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-27 Audited Results
2025-02-10 Quarterly Results
2024-11-14 Quarterly Results

Parnax Lab F&O

Parnax Lab Shareholding Pattern

72.3%
24.93%
2.77%

About Parnax Lab

  • NSE Symbol
  • PARNAXLAB
  • BSE Symbol
  • 506128
  • Managing Director & CEO
  • Mr. Mihir Prakash Shah
  • ISIN
  • INE383L01019

Similar Stocks to Parnax Lab

Parnax Lab FAQs

Parnax Lab share price is ₹132 As on 30 December, 2025 | 22:26

The Market Cap of Parnax Lab is ₹152 Cr As on 30 December, 2025 | 22:26

The P/E ratio of Parnax Lab is 13.8 As on 30 December, 2025 | 22:26

The PB ratio of Parnax Lab is 1.7 As on 30 December, 2025 | 22:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23